Japanese pharma giant Takeda is investing nearly 300 million euros ($300 million) to build a new production facility for plasma-derived therapies and a new warehouse at its existing Lessines site in Belgium.

As part of Takeda’s commitment to have net zero carbon emissions by 2030, the new facility will be self-sufficient in electricity. It will also feature a water recycling system that will cut freshwater consumption by 90 per cent by 2023. The new warehouse will itself have net zero greenhouse gas emissions.

The new plant is being built as EU countries, including Belgium, grapple with an energy crisis triggered by Russia’s halt of its natural gas supply to the region.